Prediction of prostate cancer recurrence after radiation therapy using multiparametric magnetic resonance imaging and spectroscopy: assessment of prognostic factors on pretreatment imaging.
Fiche publication
Date publication
décembre 2022
Journal
Quantitative imaging in medicine and surgery
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BERTAUT Aurélie, Pr CORMIER Luc, Dr MARTIN Etienne, Pr COCHET Alexandre, Pr LOFFROY Romaric
Tous les auteurs :
Asuncion A, Walker PM, Bertaut A, Blanc J, Labarre M, Martin E, Bardet F, Cassin J, Cormier L, Crehange G, Loffroy R, Cochet A
Lien Pubmed
Résumé
To assess whether data from pre-therapeutic multiparametric magnetic resonance imaging (mpMRI) combined with three-dimensional magnetic resonance spectroscopy (3D MRS) provide prognostic factors of biochemical relapse in patients with localized prostate cancer treated by external radiotherapy or brachytherapy.
Mots clés
Prostate, cancer, magnetic resonance imaging (MRI), radiotherapy, spectroscopy
Référence
Quant Imaging Med Surg. 2022 12;12(12):5309-5325